Medical treatment of the prostatic adenoma:
A controlled test of PA 109 {Permixon: Serenoa repens extract} vs. placebo in 100 patients
110 patients presenting with a prostatic adenoma sufficiently symptomatic to be treated medically, but not requiring surgical management, were included in a controlled test whose effectiveness was assessed after one month on the basis of objective criteria (nocturia, urinary output, post micturitional residue) and subjective criteria (dysuria, patients` opinions). PA 109 appeared significantly more effective than a placebo, especially in the objective criteria (p< 10). Perfectly tolerated, clinically and biologically, this efficacy was again found in a supplementary study of forty seven patients, with a mean follow-up of 14.5 months, and over 2-1/2 years in some cases. Under the study conditions, and on the basis of the study criteria, PA 109 seems a good treatment for micturitional disorders associated with non-surgical adenomas of the prostate.
G. Champault, A.M. Bonnard, J. Cauquil, J.C. Patel. Ann Urol 6:407-410; 1984
Home | Library Index
Manufacturers, distributors, brokers & interested parties for free monthly updates on wholesale Saw Palmetto raw materials pricing, market outlook and new clinical studies.